Hyperfractionated radiation therapy with or without concurrent low dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study. - Jeremic,B.; Shibamoto,L.; Acimovic,L.; Milisavljevic,S. (J Clin Oncol, 1996)